Recorded: 29 May 2003
So we do a lot of … One of the things that I think was probably clear from the functional genomics discussion is, we really are a sequenced based world right now. And we probably will be for a long time. And these new ultra-high throughput sequencing methods which are only going to get better. Hopefully they’ll be lots and lots of competition so it’ll drive the throughput up and the costs down and the ease of doing this even better and better. And so we’re applying that. And it’s not just my laboratory, it’s collaborations with multiple groups there, as well as some at other institutions as well…To use sequencing for the high-throughput sequencing for lots of projects in addition to the functional genomics.
Also sequencing personal genomes and probably doing this for microbial…one of the things I’m interested in, and one of the Investigators at the Institute is an expert in infectious diseases. And the idea of doing medigenomics on microbes, but also really trying to do genetics of resistance to infectious disease. I mean we’re genetic organisms obviously and we certainly have cases where there are mutations in genes that give you resistance to disease
Richard Myers, biochemist and geneticist, is currently Director of the HudsonAlpha Institute for Biotechnology in Huntsville, Alabama.
Following his undergraduate degree in biochemistry from the University of Alabama (B.S., 1977), Dr. Myers earned his Ph.D. in Biochemistry from the University of California at Berkeley (1982) with Robert Tjian. His postdoctoral work was performed at Harvard University with Tom Maniatis. In 1986 he joined the faculty of the University of California at San Francisco, and remained there until 1993 when he moved to Stanford University School of Medicine. He had been Professor and Chair of the Department of Genetics and Director of the Stanford Human Genome Center until July 2008 when he was named to his current position.
Dr. Myers is a member of numerous committees concerned with human genetic diseases and the Human Genome Project including the Genome Resources and Sequencing Prioritization Panel (GRASPP) and is Chair of the Genome Research Review Committee of the National Human Genome Research Institute of the National Institutes of Health. He is also a member of the Biology and Biotechnology Program Advisory Committee of the U.S. Department of Energy. Dr. Myers has received numerous awards including the Pritzker Foundation Award (2002), the Darden Lecture Award from the University of Alabama (2002), the Wills Foundation Award (1986-2001) and was a Searle Scholar (1987-1990).
Myers was involved in every human genome meeting at Cold Spring Harbor Laboratory and has attended CSHL symposia since 1986.